Dr. Morten L. Isaksen speaks at conference

The 4th Annual Translational Microbiome Conference is held in Boston on 18th to 20th April. The conference brings together leaders and executives from the pharmaceutical, biotech, academic, and government communities to discuss the potential for translational interventions in microbiome research, and the challenges the industry will need to address to make this space successful.

Dr. Morten L. Isaksen, CEO of Bio-Me, has been selected as one of the first four main speakers of the conference. His talk is entitled “A Microbiome-based Approach to Precision Medicine and Personalized Nutrition” and will cover new data from Bio-Me and how gut microbiome analysis can give significant contributions to better health care and prevention.